Posted in | News | Nanoenergy | Nanobusiness

Company to Develop Low-Cost, High-Efficiency, Flexible Form Factor, Crystalline-Silicon Thin-Film PV Solutions

Ampulse Corporation, a developer and manufacturer of solar cell solutions based on proprietary and patented crystalline-silicon (c-Si) thin-film technology, today announced it has closed an $8 million Series A funding co-led by Globespan Capital Partners and El Dorado Ventures, and joined by existing investors Battelle Ventures and its affiliate fund, Innovation Valley Partners.

As a result of the funding, Daniel Leff of Globespan Capital Partners and Jeff Hinck of El Dorado Ventures have joined Ampulse’s board of directors.

Ampulse’s technology blends the best efficiency properties of c-Si with the attractive manufacturing costs and application flexibilities of emerging thin-film photovoltaic (PV) technologies. Ampulse’s manufacturing process uses a patented breakthrough technique to deposit c-Si on a flexible substrate, the material of choice for PV applications.

“Ampulse has assembled a strong management team along with key strategic partnerships with two renowned laboratories to develop a low-cost, high efficiency, c-Si thin-film PV solution for the residential, commercial, and utility-scale solar markets,” said Daniel Leff, venture partner with Globespan Capital Partners. “Additionally, I am delighted to serve on the board and contribute to the success of a company whose solution is one of the most disruptive I have ever seen in the solar market.”

“The commitment from our new venture partners provides us the support that will help us bring our innovative c-Si thin-film technology to market, “said Steve Hane, president and chief executive officer of Ampulse. “Through our research partnerships with the National Renewable Energy Laboratory (NREL) and the Oak Ridge National Laboratory (ORNL), Ampulse’s next-generation c-Si thin-film technology will deliver a highly efficient and flexible form factor thin-film solution with the lowest total system cost to address the needs of our customers.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.